118 related articles for article (PubMed ID: 14723959)
1. Synthesis, biological, and chiroptical activity of 3-phenyl-clavams.
Cierpucha M; Solecka J; Frelek J; Szczukiewicz P; Chmielewski M
Bioorg Med Chem; 2004 Jan; 12(2):405-16. PubMed ID: 14723959
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 3-Substituted-clavams: Antifungal Properties, DD-Peptidase and beta-Lactamase Inhibition.
Cierpucha M; Panfil I; Danh TT; Chmielewski M; Kurzatkowski W; Rajnisz A; Solecka J
J Antibiot (Tokyo); 2007 Oct; 60(10):622-32. PubMed ID: 17965478
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric studies on the inhibition of TEM-2 beta-lactamase by clavulanic acid derivatives.
Brown RP; Aplin RT; Schofield CJ; Frydrych CH
J Antibiot (Tokyo); 1997 Feb; 50(2):184-5. PubMed ID: 9099233
[No Abstract] [Full Text] [Related]
4. Structure-chiroptical properties relationship in oxabicyclic beta-lactam derivatives.
Frelek J; Lysek R; Borsuk K; Jagodziński J; Furman B; Klimek A; Chmielewski M
Enantiomer; 2002; 7(2-3):107-14. PubMed ID: 12108627
[TBL] [Abstract][Full Text] [Related]
5. Structure-chiroptical properties relationship in clavams: an experimental and theoretical study.
Chmielewski M; Cierpucha M; Kowalska P; Kwit M; Frelek J
Chirality; 2008 May; 20(5):621-7. PubMed ID: 17924419
[TBL] [Abstract][Full Text] [Related]
6. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
Sandanayaka VP; Prashad AS
Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
[TBL] [Abstract][Full Text] [Related]
7. Stereocontrolled formation of oxacephams from carbohydrates.
Borsuk K; Kazimierski A; Solecka J; Urbańczyk-Lipkowska Z; Chmielewski M
Carbohydr Res; 2002 Nov; 337(21-23):2005-15. PubMed ID: 12433466
[TBL] [Abstract][Full Text] [Related]
8. A semi-empirical study of some clavulanic acid derivatives in relation to their activity as beta-lactamase inhibitors.
Fernández B; Ríos MA
J Pharm Pharmacol; 1993 Jan; 45(1):25-9. PubMed ID: 8094441
[TBL] [Abstract][Full Text] [Related]
9. Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. III. Absolute stereochemistry.
Müller JC; Toome V; Pruess DL; Blount JF; Weigele M
J Antibiot (Tokyo); 1983 Mar; 36(3):217-25. PubMed ID: 6833142
[TBL] [Abstract][Full Text] [Related]
10. Practical use of DD-peptidase 64-575 for the assay of inhibition activity of natural and synthetic beta-lactam compounds.
Solecka J; Lysek R; Furman B; Chmielewski M; Kurzatkowski W
Acta Pol Pharm; 2003; 60(2):115-8. PubMed ID: 13678318
[TBL] [Abstract][Full Text] [Related]
11. Chemistry and biosynthesis of clavulanic acid and other clavams.
Baggaley KH; Brown AG; Schofield CJ
Nat Prod Rep; 1997 Aug; 14(4):309-33. PubMed ID: 9281835
[No Abstract] [Full Text] [Related]
12. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA
Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342
[TBL] [Abstract][Full Text] [Related]
13. 5-Dethia-5-oxacephams: toward correlation of absolute configuration and chiroptical properties.
Łysek R; Borsuk K; Chmielewski M; Kałuza Z; Urbańczyk-Lipkowska Z; Klimek A; Frelek J
J Org Chem; 2002 Mar; 67(5):1472-9. PubMed ID: 11871875
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
Brown RP; Aplin RT; Schofield CJ
Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications.
Sutherland R
Infection; 1995; 23(4):191-200. PubMed ID: 8522374
[No Abstract] [Full Text] [Related]
16. Strategies for the stereocontrolled formation of oxygen analogues of penicillins and cephalosporins.
Łysek R; Borsuk K; Furman B; Kałuza Z; Kazimierski A; Chmielewski M
Curr Med Chem; 2004 Jul; 11(14):1813-35. PubMed ID: 15279570
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
18. Cysteine derivatives as inhibitors for carboxypeptidase A: synthesis and structure-activity relationships.
Park JD; Kim DH
J Med Chem; 2002 Feb; 45(4):911-8. PubMed ID: 11831903
[TBL] [Abstract][Full Text] [Related]
19. Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Kelly JA; Frère JM; Klein D; Ghuysen JM
Biochem J; 1981 Oct; 199(1):129-36. PubMed ID: 6279094
[TBL] [Abstract][Full Text] [Related]
20. Evolution of beta-lactamase inhibitors.
Rolinson GN
Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
